CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

ts-172

Small moleculeexperimental

Clinical trial activity

12 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
5
Phase 3
3
Phase 4
0

Earliest trial started Aug 16, 2021 (NCT04979572)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07285291Phase 3Jan 5, 2026Taisho Pharmaceutical
NCT07285304Phase 3Dec 1, 2025Taisho Pharmaceutical
NCT07231029Phase 1Nov 30, 2025Taisho Pharmaceutical
NCT07084961Phase 1Aug 5, 2025Taisho Pharmaceutical
NCT06849778Phase 1Mar 17, 2025Taisho Pharmaceutical
NCT06837142Phase 1Mar 11, 2025Taisho Pharmaceutical
NCT06837155Phase 1Mar 3, 2025Taisho Pharmaceutical
NCT06745518Phase 2Jan 13, 2025Taisho Pharmaceutical
NCT06745531Phase 3Jan 13, 2025Taisho Pharmaceutical
NCT06596356Phase 1Sep 26, 2024Taisho Pharmaceutical
NCT05699239Phase 2Feb 8, 2023Taisho Pharmaceutical
NCT04979572Phase 1Aug 16, 2021Taisho Pharmaceutical
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Taisho PharmaceuticalFor profit121232021
1 organizations
Page 1 / 1